Acceso abierto·Documento·2022·Inglés

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Thiago Cerqueira-Silva; Jason R Andrews; Viviane S Boaventura; Otavio T Ranzani; Vinicius de Araújo Oliveira; Enny S Paixão; Juracy Bertoldo Júnior; Tales Mota Machado; Matt D T Hitchings; Murilo Dorion; Margaret L Lind; Gerson O Penna; Derek A T Cummings; Natalie E Dean; Guilherme Loureiro Werneck; Neil Pearce; Mauricio L Barreto; Albert I Ko; Julio Croda; Manoel Barral-Netto

Openalex

Cómo citar

Thiago Cerqueira-Silva, & Jason R Andrews, & Viviane S Boaventura, & Otavio T Ranzani, & Vinicius de Araújo Oliveira, & Enny S Paixão, & Juracy Bertoldo Júnior, & Tales Mota Machado, & Matt D T Hitchings, & Murilo Dorion, & Margaret L Lind, & Gerson O Penna, & Derek A T Cummings, & Natalie E Dean, & Guilherme Loureiro Werneck, & Neil Pearce, & Mauricio L Barreto, & Albert I Ko, & Julio Croda, & Manoel Barral-Netto (2022). Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. https://doi.org/10.1016/s1473-3099(22)00140-2

Leer PDF DOI: 10.1016/s1473-3099(22)00140-2